18FDG-PET applications for cartilage neoplasms

Skeletal Radiology

Volumn 34, Issue 7, 2005, Pages 367-374

  Feldman, Frieda ^a   Van Heertum, Ronald ^a   Saxena, Chitra ^a   Parisien, May ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Bone tumors; Cartilage; Neoplasms; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TRANSPLANTATION; CANCER MORTALITY; CARTILAGE TUMOR; CHONDROSARCOMA; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; ENCHONDROMA; EXOSTOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MALE; METASTASIS; OSTEOCHONDROMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR RECURRENCE; WHOLE BODY SCINTISCANNING; BONE TUMOR; CHILD; CHONDROMA; CHONDROPATHY; MIDDLE AGED; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARTILAGE DISEASES; CHILD; CHONDROMA; CHONDROSARCOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; OSTEOCHONDROMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 22144499248     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-005-0894-y     Document Type: Article

References (27)

1. Evans HL, Ayala AG, Romsdah MM. Prognostic factors in chondrosarcoma of bone. Cancer 1977; 40:818-831
2. Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft tissue tumors J Bone Joint Surg Am 1982; 64:1121-1127. 1:STN:280:BiyD3s%2FovFw%3D
3. Rosenthal DJ, Schiller AL, Mankin HJ. Chondrosarcoma: Correlation of radiological and histological grade. Radiology 1984; 150:21-26. 1:STN:280:BiuD2s7mvF0%3D
4. Unni K. Dahlin's bone tumors: General aspects and data on 11,087 cases, 5th edn. Philadelphia: Lippincott-Raven, 1996:143-183
5. Som P, Atkins HL, Bandaypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-glucose (F18): Nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21:670-675. 1:CAS:528:DyaL3cXltlSiur4%3D
6. Messa C, Landoni C, Pozzaato C, et al. Is there a role for FDG-PET in the diagnosis of musculoskeletal neoplasms? J Nucl Med 2000; 41:170-317 [AU: PLEASE CHECK PAGE NOS.]
7. Cook G, Fogelman I. The role of positron emission tomography in skeletal disease. Semin Nucl Med 2001; 31:50-61. 1:STN:280:DC%2BD3M7ptFygtg%3D%3D
8. Kole AC, Nieweg OE, Hoekstra HJ, et al. F18 assessment of glucose metabolism in bone tumors. J Nucl Med 1998; 39:810-815. 1:CAS:528:DyaK1cXjsVShur4%3D
9. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1998; 29:181-186
10. 18)-fluoro-2-deoxy-d-glucose. Radiology 1996; 200:243-247. 1:STN:280:BymB2Mjhs10%3D
11. 18) fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998; 4:1215-1220
12. Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mol Imaging 2004; 31:189-195. 10.1007/s00259-003-1353-4
13. Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: Evaluation by FDG PET. J Nucl Med 2000; 41:1695-1701. 1:STN:280:DC%2BD3cvoslOnsA%3D%3D
14. Gilkey FW, Moser RP. The biology of cartilage. In: Moser RP, ed. Cartilaginous tumors of the skeleton. Philadelphia: Hanley and Belfus, 1990:1-7
15. 18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol 2003; 32:201-208. 12652335
16. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr 1999; 23:603-608. 10.1097/00004728-199907000-00022
17. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions. Radiology 2001; 219:774-777. 1:STN:280:DC%2BD3Mzis1Grtw%3D%3D
18. Arsos G, Venizelos I, Karatzas N, et al. Low grade chondrosarcomas: A difficult target for radionuclide imaging. Eur J Radiol 2002; 43:66-72. 10.1016/S0720-048X(01)00427-2
19. 18F]fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238. 3712040
20. Pritchard D, Unni K. Chondrosarcoma. International Skeletal Society closed meeting syllabus, Stockholm, Sweden, Aug 25, 1992.
21. Personal communication, Prof. G. Steiner, Chief of Pathology, Orthopedic Institute, NYC.
22. Bredella M, Caputo GR, Steinbach LS. Value of PDG positron imaging in conjunction with MRI for evaluating therapy response in patients with musculoskeletal sarcomas. AJR Am J Roentgenol 2002; 179:1145-1150. 12388489
23. Franzius C, Sciuk, J, Brinkschmidt C, et al. Evaluation of chemo-therapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25:874-881. 10.1097/00003072-200011000-00004
24. Franzius C, Daldrup-Link, H, Wagner-Bohn A, et al. FDG-PET for detection of recurrences from malignant primary bone tumors: Comparison with conventional imaging. Ann Oncol 2002; 13:157-160. 10.1093/annonc/mdf012
25. 18) fluoro-2-deoxy-d-glucose. Variations with body weight and a method for correction. Radiology 1993; 89:847-850.
26. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine 18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissue studied by microautoradiography. J Nucl Med 1992; 33:1972-1980. 1:CAS:528:DyaK3sXns1aktw%3D%3D
27. Guhlmann A, Brechy-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998; 206:749-754. 1:STN:280:DyaK1c7lsFKjsg%3D%3D